The proinflammatory activity of FABP4 in macrophages has been reported previously in the context of obesity, atherosclerosis, and nonalcoholic fatty liver disease (15, 18, 37). The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatotic liver disease.